세계의 Drug Discovery 기술 시장 규모는 2024년 1,119억 달러에서 예측 기간 중 CAGR 12.0%로 추이하며, 2029년말에는 1,970억 달러 규모에 달할 것으로 예측됩니다.
바이오 분석 기기 부문은 2024년 300억 달러에서 CAGR 10.9%로 추이하며, 2029년말에는 503억 달러에 달할 것으로 예측됩니다. 또한 High Throughput Screening 부문은 2024년 250억 달러에서 CAGR 11.9%로 추이하며, 2029년말에는 439억 달러에 달할 것으로 예측됩니다.
세계의 Drug Discovery 기술 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신규 기술 및 기술개발 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
Porter's Five Forces 분석
제3장 시장 역학
시장 역학
시장 성장 촉진요인
Drug Discovery 하이컨텐트 스크리닝(HCS) 기술
기술의 진보
맞춤형 의료의 수요
만성질환 및 면역 질환의 이환율 상승
고령자 인구의 증가
연구 자금의 가용성
시장 성장 억제요인
Drug Discovery 프로세스와 기기의 비용
엄격한 규제
분자 메커니즘의 보다 깊은 이해
시장 기회
Drug Discovery에서 AI의 가능성
제4장 신규 기술
개요
AI
제5장 시장 세분화 분석
세분화 내역
세계의 Drug Discovery 기술 시장 : 기술별
세계 시장의 예측
High Throughput Screening(HTS)
바이오 분석 기기
유전체학
단백질체학
세포 기반 어세이와 시약
바이오인포매틱스
기타
세계의 Drug Discovery 기술 시장 : 질환별
세계 시장의 규모와 예측
종양
심장병
신경변성질환
면역 질환
기타
세계의 Drug Discovery 기술 시장 : 최종사용자별
세계 시장의 규모와 예측
바이오의약품 기업
연구·학술
CRO
지역적 내역
세계의 Drug Discovery 기술 시장 : 지역별
세계 시장의 규모·예측
북미
유럽
아시아태평양
기타
제6장 경쟁 정보
경쟁 구도
기업의 시장 점유율 분석
SWOT 분석
제7장 약물전달 기술 시장의 지속가능성 : ESG 관점
ESG : 서론
Drug Discovery 기술 업계의 지속가능성
ESG의 시점
환경에 대한 영향
사회적 영향
거버넌스의 영향
제8장 부록
조사 방법
약어
전시
기업 개요
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
DANAHER CORP.
ILLUMINA INC.
PROMEGA CORP.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
KSA
영문 목차
영문목차
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
The bioanalytical instruments market for drug discovery technologies is expected to grow from $30.0 billion in 2024 and is projected to reach $50.3 billion by the end of 2029, at a CAGR of 10.9% during the forecast period of 2024 to 2029.
The high-throughput screening market for drug discovery technologies is expected to grow from $25.0 billion in 2024 and is projected to reach $43.9 billion by the end of 2029, at a CAGR of 11.9% during the forecast period of 2024 to 2029.
Report Scope:
This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies' current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.
The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.
The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.
The report's goals include:
Analyzing technologies and applications.
Analyzing global market size and segmentation.
Identifying market constraints and drivers.
Providing detailed market forecasts through 2029.
Assessing market shares, competitiveness, and industry structure.
Identifying potential long-term impacts on the drug discovery technologies market.
Report Includes:
104 data tables and 34 additional tables
An analysis of the current and future global markets for drug discovery technologies
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
Discussion of bioinformatics as a platform for drug discovery
A comparison between proteomics and genomics drug discovery technology
Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
High-Content Screening (HCS) Techniques in Drug Discovery
Technological Advances
Demand for Personalized Medicine
Rising Prevalence of Chronic and Immunological Diseases
Growing Elderly Population
Availability of Research Funds
Market Restraints
Cost of the Drug Discovery Process and Instruments
Stringent Regulations
Better Understanding of Molecular Mechanisms
Market Opportunities
Potential for AI in Drug Discovery
Chapter 4 Emerging Technologies
Overview
AI
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Drug Discovery Technologies, by Technology
Global Market Forecast
High-Throughput Screening (HTS)
Bioanalytical Instruments
Genomics
Proteomics
Cell-Based Assays and Reagents
Bioinformatics
Other Technologies
Market for Drug Discovery Technologies, by Disease Application
Global Market Size and Forecast
Oncology
Cardiology
Neurodegenerative Diseases
Immunological Diseases
Other Diseases
Global Market for Drug Discovery Technologies, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Research and Academia
Contract Research Organizations (CROs)
Geographic Breakdown
Global Market for Drug Discovery Technologies, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World
Chapter 6 Competitive Intelligence
Competitive Landscape
Analysis of Companies' Market Shares
SWOT Analysis
Strengths
Challenges
Opportunities
Threats
Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective
Introduction to ESG
Sustainability in the Drug Discovery Technologies Industry
